Search

Your search keyword '"Rammensee, Hans‐Georg"' showing total 1,011 results

Search Constraints

Start Over You searched for: Author "Rammensee, Hans‐Georg" Remove constraint Author: "Rammensee, Hans‐Georg" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
1,011 results on '"Rammensee, Hans‐Georg"'

Search Results

1. A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2

2. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

3. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

4. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts

5. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma

6. The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination

7. Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

8. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma* [S]

10. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

11. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

14. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity

16. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

17. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells

18. P480: DNMT AND HDAC INHIBITION INDUCES IMMUNOGENIC NEOANTIGENS FROM HUMAN ENDOGENOUS RETROVIRAL ELEMENT-DERIVED TRANSCRIPTS

20. The immunopeptidomic landscape of ovarian carcinomas

21. Actively personalized vaccination trial for newly diagnosed glioblastoma

28. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

31. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

35. A T-cell antigen atlas for meningioma: novel options for immunotherapy

36. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

39. T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells

40. IMMU-28. THE INTRA-TUMORAL SPATIAL HETEROGENEITY OF T CELL ANTIGENS IN GLIOBLASTOMA: AN INTEGRATED MULTI-OMICS APPROACH

41. 64 Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET

44. “Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015

45. Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade

47. IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases

48. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications

49. Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during checkpoint blockade

50. Abstract CT258: Interim safety and immunogenicity results of a phase I trial evaluating the multi-peptide COVID-19 vaccine candidate CoVac-1 for induction of SARS-CoV-2 T cell immunity in cancer patients with disease- or treatment-related immunoglobulin deficiency

Catalog

Books, media, physical & digital resources